Introduction {#Sec1}
============

In the developed world, national identification numbers are predominantly used to identify patients \[[@CR1]\]. However, in many countries these are unavailable, requiring novel techniques for patient identification. New cost-effective and practical options are therefore being developed, such as biometric identification \[[@CR2], [@CR3]\]. A successful biometric tool should be easy to operate, capable of identifying entire populations, suitable for the developed and developing world, able to generate reproducible results, and cost-effective.

Current biometric identification methods include fingerprinting, facial recognition, iris scanning, and voice recognition \[[@CR4]--[@CR7]\]. Fingerprint identification is the furthest developed, affordable and easy to use. Hence, it has been successfully implemented for use with adults in healthcare systems globally \[[@CR8]--[@CR11]\].

Patient identification during early childhood is important as most vaccinations schedules initiated at this stage \[[@CR12], [@CR13]\]. However, fingerprint identification is suboptimal in young children as they have a shorter distance between structural ridges in the fingerprint compared with later life, make the fingerprint indistinct. As children grow, the ridge distances increase and the scanning device will eventually not be able to identify the same individual \[[@CR11], [@CR14]\].

As chaotic morphogenesis occurs in utero, distinctive iris patterns remain the same throughout life \[[@CR15]\]. Therefore, this technique may be suitable for identification of children \[[@CR9], [@CR16]\]. It is affordable, and, being a contact-free process, may prevent transmission of infectious disease \[[@CR17]--[@CR19]\]. However, iris scanning methodology is currently limited and identification of patients aged 1--4 years relies upon the biometrics of a parent/guardian \[[@CR9]\].

We conducted two exploratory studies and one larger clinical study to determine the usability of iris scanning through assessing accuracy of identifying children aged 1‒4 years.

Main text {#Sec2}
=========

Exploratory studies {#Sec3}
-------------------

Two exploratory, open-label, methodological studies were performed; one in Belgium (June--November 2016) and one in Sierra Leone (March--May 2017). Healthy children were recruited from daycare centers, pre-schools, health centers, and an event for children.

Ethical approval was obtained from the independent ethics committees/institutional review boards in each country. Legal guardians of all children provided written informed consent. Both studies were performed in accordance with current International Council on Harmonization guidelines on Good Clinical Practice, applicable regulatory and country-specific requirements, and the Declaration of Helsinki.

The studies were carried out by Johnson & Johnson's Clinical Pharmacology Unity and World Vision Sierra Leone. Image capture and data matching were performed as described for the clinical study. Usability and feasibility of the procedure were assessed using weighted five-point scales. Adverse events and safety information reported by investigators were recorded.

Clinical study {#Sec4}
--------------

### Study population {#Sec5}

Children were recruited from a community pre-school and three primary healthcare units in Sierra Leone (June--December 2017). Inclusion criteria included minors 1--4 years old (inclusive); able to open eyes; no recent eye infections; and not receiving eye medication.

### Equipment for procedure {#Sec6}

The study was performed by World Vision Sierra Leone. The iris scanning procedure was performed using an IriShield MK 2120 monocular camera (Iritech, Inc.), and a Galaxy Tab S2 8″ 32 GB BT tablet and Neurotechnology iris scanning algorithms.

### Image capture {#Sec7}

An initial capture of each iris was conducted for biometric registration. A second image pair was then captured for recognition at the same visit. The camera was held approximately 5 cm from the child's eye and automatically captured the image once the iris was in focus.

### Data matching {#Sec8}

Successful iris scans were assessed for quality and surface. Quality was defined as how well a recognition template was created from the raw image, proprietary to the camera manufacture. Surface was a measure of how much surface of the iris could be used for the template. A quality threshold of 70, based on our experience in adults and to preserve a single methodology, was applied to produce good quality images whilst reducing the need for frequent recaptures.

To analyze image data, sensitivity and specificity was measured. Sensitivity measured the proportion of correctly accepted enrolled/registered patients, and specificity the proportion of correctly rejected participants who were not enrolled/registered.

Authenticity between first and second image pairs was ensured by capturing both in one session assigning one subject ID. To assess sensitivity (specificity), the second pair is matched against the full data set of first pairs, including (excluding) the individual under investigation.

### Usability and feasibility of the procedure {#Sec9}

Usability of the device and cooperation of the child were assessed using five survey questions (Additional file [1](#MOESM1){ref-type="media"}: Table S1). An additional five-point survey was conducted to obtain feedback on the ease-of-use on a scale of 1 = difficult to 5 = easy, with the opportunity to provide written comments.

Overall usability was calculated using a weighted sum of scores for survey questions and the five-point question. Arbitrarily, a 'not usable' result was defined as ≥ 3 'Yes' responses and a score of \< 3 on the difficulty scale. The lowest aggregate score was 1.45, which was defined as the usability threshold. Participants in whom matching could not be performed were included as failures.

Usability scores were analyzed across all participants, and for each age category. Feasibility was assessed based on the number of participants who were not included due to an insufficient number of images.

### Statistics and data analysis {#Sec10}

Statistical analyses were performed using a logistic model or generalized estimating equations, including age as a continuous covariate.

Usability survey data were summarized using descriptive statistics, overall and by age category. Comments were collected verbatim.

Sensitivity, specificity, and feasibility were assessed using a logistic model with age as categorical covariate. Sensitivity and specificity were compared to the current standard of identification using non-inferiority testing with a 5% threshold. The quality of iris recognition in adults was also compared in a superiority test.

### Safety and tolerability {#Sec11}

All adverse events and any safety information spontaneously reported by an investigator were recorded.

Results {#Sec12}
-------

### Exploratory studies {#Sec13}

427 children were recruited into two exploratory studies (n = 197 in Belgium; n = 230 in Sierra Leone). The number of iris scans captured was 1660 in Belgium and 2109 in Sierra Leone. Overall, 22.4% and 39.4% of these were successful. In Belgium, 46.2% of participants had ≥ 2 images captured successfully. In Sierra Leone, the success rate was substantially higher, with 90.4% of participants having ≥ 2 successful images captured.

In both studies, the percentage of successful images, proportion of individuals with ≥ 2 successful images and the number of children eligible for matching increased with age.

Compared with standard identification of infants using a parent/guardian biometric, specificity was non-inferior within a 5% threshold for all age groups. Sensitivity was also non-inferior among participants aged 2--4 years in Belgium, but fell outside of the accepted range for non-inferiority in Sierra Leone. As the feasibility of iris scan imaging was very low, non-inferiority compared with the current approach could not be concluded for sensitivity and specificity in Belgium and for sensitivity in Sierra Leone; specificity results were high enough in Sierra Leone in participants aged 2--4 years.

In Belgium, there was frequently a requirement of physical contact, multiple iris captures, and help from a guardian during the scanning process. Some operators also reported that the device made contact with the participant or that capturing an image of the iris was impossible due to the child being afraid of the device. The mean usability score of 1.3308 was below the threshold of 1.45 required for routine use. However, mean scores were above the usability threshold in those aged 3 and 4 years (1.53 and 1.68, respectively). Corresponding data were not available from Sierra Leone due to large variability and poor quality of survey sheets. Learnings from these studies were used in designing the clinical study, including improved operator training and positioning of the iris image, and an increased quality assessment threshold.

### Clinical study {#Sec14}

#### Baseline characteristics {#Sec15}

635 healthy children were recruited into the study; 71% were aged 1--2 years. No adverse events were reported, and no participants withdrew due to safety reasons.

#### Iris scan capture---procedure performance {#Sec16}

14,958 iris scans were captured and 2138 (14.3%) were successful (Additional file [2](#MOESM2){ref-type="media"}: Figure S1). The number of successful images per individual was high; 86.0% of participants had ≥ 2 successful images captures and 81% successfully had four images captured (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Number of successful iris scans per individual in infants in Sierra Leone (n = 635). n is provided at the bottom of each bar

#### Effect of age on iris scan capture performance {#Sec17}

The percentage of successful images captured increased with age, from 10% in 1-year-olds to 24% in aged 4-year-olds (Additional file [2](#MOESM2){ref-type="media"}: Figure S1). The proportion of individuals with ≥ 2 successful images also increased with age (*p *\< 0.0001; Fig. [1](#Fig1){ref-type="fig"}).

#### Quality and surface values of iris scans {#Sec18}

The overall quality and surface value of iris scans were similar over the age range studied (Additional file [3](#MOESM3){ref-type="media"}: Figure S2a). Similar quality and surface values of iris scans were seen in the slightly smaller subset in the matching database (Additional file [3](#MOESM3){ref-type="media"}: Figure S2b).

#### Matching procedure {#Sec19}

81% of participants were eligible for the matching procedure. The number of eligible children increased with age (1 year: 62.8%; 2 years: 86.0%; 3 years: 93.9%; 4 years: 99%; *p *\< 0.0001).

#### Specificity and sensitivity comparison to other approaches {#Sec20}

Across all age groups, sensitivity and specificity were similar, and non-inferior to current methods. Compared with the quality of iris scans in adults, overall specificity and sensitivity were less accurate across all age groups (*p *\< 0.0001), except for sensitivity of 3-year-olds in the matching population (*p *= 1.000). The results of the logistic model in which age and study were covariates are shown in Table [1](#Tab1){ref-type="table"}.Table 1Sensitivity and specificity analysis (clinical study; n = 635 \[Sierra Leone\])---logistic modelAgeEstimate (95% CI)*p* value vs infant identification using parent/guardian performance accuracy*p* value vs adult performance accuracySensitivity in matching population 1 year0.896 (0.834--0.936)0.0028\< 0.0001 2 years0.932 (0.886--0.960)\< 0.0001\< 0.0001 3 years1.0000 (0.961--1.000)\< 0.00011.0000^a^ 4 years0.988 (0.921--0.998)0.0013\< 0.0001Specificity in matching population 1 year0.993 (0.952--0.999)0.0002\< 0.0001 2 years0.948 (0.905--0.972)\< 0.0001\< 0.0001 3 years0.946 (0.876--0.977)0.0007\<0.0001 4 years0.918 (0.837--0.960)0.0050\< 0.0001Sensitivity in enrolled participants (instances in which the matching procedure could not be performed included as failures) 1 year0.563 (0.498--0.626)1.0000\< 0.0001 2 years0.802 (0.744--0.849)0.4955\< 0.0001 3 years0.939 (0.870--0.972)0.0008\< 0.0001 4 years0.977 (0.912--0.994)0.0005\< 0.0001Specificity in enrolled participants (instances in which the matching procedure could not be performed included as failures) 1 year0.624 (0.560--0.685)1.0000\< 0.0001 2 years0.815 (0.759--0.861)0.3030\< 0.0001 3 years0.888 (0.809--0.937)0.0178\< 0.0001 4 years0.907 (0.825--0.953)0.0088\< 0.0001Analysis based on logistic models for sensitivity and specificity with age as covariate^a^Exact testing was performed for sensitivity in 3-year-olds

#### Feasibility analysis {#Sec21}

Feasibility was different between the younger (1-to-2-year-old) and older (3-to-4-year-old) infants. As such, non-inferiority compared with the current approach could only be concluded within the older age group, for both sensitivity and specificity (Table [1](#Tab1){ref-type="table"}).

#### Usability {#Sec22}

Physical contact with the operator was required for 379 participants (60%), while four (1%) were in contact with the device. Multiple captures were required for 299 participants (48%), and help was needed from the accompanying adult in 52% of cases. 98 participants (16%) were afraid of the device, making iris image capturing impossible. Overall, mean difficulty rating for use of the device was 2.36 ± 1.11.

The mean (total) usability score of 1.55 ± 0.27 was above the 1.45 usability threshold required for routine use. The highest score was observed in 4-year-olds (1.64 ± 0.22; 4); and was below the usability threshold for 1-year-olds (1.41 ± 0.28) (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Usability scores according to participant age, assessed using operator survey results (clinical study; n = 635 \[Sierra Leone\]). Box and whiskers plots indicating median (horizontal line), upper and lower quartiles (boxes), and range (whiskers). Numerical values provided within each box represent the mean. The horizontal dashed line represents the usability threshold (1.45). The number of survey responses is provided at the base of each plot

Discussion {#Sec23}
----------

We aimed to address the critical need for accurate identification of minors to ensure they receive correct vaccination schedules, based on the potential benefits of iris scanning \[[@CR9], [@CR16], [@CR20]\]. This clinical study shows that iris scanning was non-inferior to current standard identification approaches in children aged 3--4.

The exploratory studies demonstrated the potential of iris scanning in children, but highlighted technical issues that were subsequently resolved for the clinical study. Changes included improved operator training, controlled environmental conditions, and a higher quality threshold.

Nevertheless, issues were encountered in the clinical study, which must yet be overcome for iris scanning technology to become a clinically applicable method of identification with children. The iris is small and can be obscured, which can impede capture. Difficulties also occur when obtaining a scan in non-cooperative infants---the iris is a 'moving' target that must remain motionless for capture, and operators needed multiple captures per eye in many instances. This may be overcome by new technologies that can capture the iris in motion.

One of the major drivers for the investigation of iris scanning was that it would avoid contact, thus mitigating transmission of diseases \[[@CR9]\]. However, technology operators completing the survey also noted that they made physical contact with the participant ≥ 50% of the time.

Conclusions {#Sec24}
-----------

We have documented evidence on the age threshold at which iris scanning can be used in minors instead of using the biometrics of a parent/guardian. We can conclude that iris scanning is non-inferior in children aged 3--4 years, allowing for uniformity of the process. For younger children, several outstanding issues need to be addressed. However, this procedure has clear potential to identify minors, with wide-scale application in the developing world.

Limitations {#Sec25}
===========

Four images were necessary to perform matching; in a real-world setting, two images per visit would be sufficient.Feasibility may have been underestimated.

Additional files
================

 {#Sec26}

**Additional file 1: Table S1.** Usability survey questions answered by biometric operators for each participant. **Additional file 2: Figure S1.** Iris scanning capture in infants in Sierra Leone (n = 569). 66 participants without age data are omitted from overall data in Fig. [1](#Fig1){ref-type="fig"}. n is provided at the bottom of each bar. **Additional file 3: Figure S2.** (a) Quality and surface of successful iris captures in enrolled participants in Sierra Leone (2138 images), (b) quality and surface of recognition iris scans in the matching population database (2048 images) across the different age range (1‒4 years) in Sierra Leone. Box and whiskers plots indicating median (horizontal line), upper and lower quartiles (boxes), and range (whiskers), with outliers plotted as individual points. Numerical values provided within each box represent the mean. The number of images is provided at the base of each bar.
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